Gohealth, Inc. (GOCO)

$13.57

+0.21

(+1.57%)

Market is closed - opens 7 PM, 22 Jul 2024

Performance

  • $13.11
    $13.57
    $13.57
    downward going graph

    3.39%

    Downside

    Day's Volatility :3.39%

    Upside

    0.0%

    downward going graph
  • $8.52
    $19.82
    $13.57
    downward going graph

    37.21%

    Downside

    52 Weeks Volatility :57.01%

    Upside

    31.53%

    downward going graph

Returns

PeriodGohealth, Inc.Russel 2000Index (Russel 2000)
3 Months
27.24%
0.0%
0.0%
6 Months
7.74%
0.0%
0.0%
1 Year
-26.43%
0.0%
0.0%
3 Years
-90.52%
-17.0%
-17.0%

Highlights

Market Capitalization
317.7M
Book Value
$22.82
Earnings Per Share (EPS)
-7.11
Wall Street Target Price
18.33
Profit Margin
-8.59%
Operating Margin TTM
-2.17%
Return On Assets TTM
-2.86%
Return On Equity TTM
-29.76%
Revenue TTM
737.1M
Revenue Per Share TTM
77.76
Quarterly Revenue Growth YOY
1.3%
Gross Profit TTM
444.0M
EBITDA
30.7M
Diluted Eps TTM
-7.11
Quarterly Earnings Growth YOY
4.24
EPS Estimate Current Year
-5.7
EPS Estimate Next Year
-4.51
EPS Estimate Current Quarter
-0.95
EPS Estimate Next Quarter
-2.44

Analyst Recommendation

Buy
    77%Buy
    22%Hold
    0
    0%Sell
Based on 9 Wall street analysts offering stock ratings for Gohealth, Inc.(by analysts ranked 0 to 5 stars)
Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
2
2
2
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 35.08%

Current $13.57
Target $18.33

Company Financials

FY18Y/Y Change
Revenue
226.2M
-
Net Income
28.1M
-
Net Profit Margin
12.43%
-
FY19Y/Y Change
Revenue
539.5M
↑ 138.5%
Net Income
-41.1M
↓ 246.06%
Net Profit Margin
-7.61%
↓ 20.04%
FY20Y/Y Change
Revenue
877.4M
↑ 62.62%
Net Income
-97.2M
↑ 136.68%
Net Profit Margin
-11.08%
↓ 3.47%
FY21Y/Y Change
Revenue
1.1B
↑ 21.09%
Net Income
-534.2M
↑ 449.58%
Net Profit Margin
-50.28%
↓ 39.2%
FY22Y/Y Change
Revenue
631.7M
↓ 40.54%
Net Income
-376.4M
↓ 29.54%
Net Profit Margin
-59.59%
↓ 9.31%
FY23Y/Y Change
Revenue
734.7M
↑ 16.31%
Net Income
-63.3M
↓ 83.19%
Net Profit Margin
-8.61%
↑ 50.98%
Q4 FY22Q/Q Change
Revenue
69.4M
↓ 47.86%
Net Income
-150.7M
↑ 275.42%
Net Profit Margin
-217.28%
↓ 187.1%
Q1 FY23Q/Q Change
Revenue
183.2M
↑ 164.01%
Net Income
-22.5M
↓ 85.04%
Net Profit Margin
-12.31%
↑ 204.97%
Q2 FY23Q/Q Change
Revenue
142.8M
↓ 22.05%
Net Income
-28.9M
↑ 28.39%
Net Profit Margin
-20.27%
↓ 7.96%
Q3 FY23Q/Q Change
Revenue
132.0M
↓ 7.52%
Net Income
-23.9M
↓ 17.39%
Net Profit Margin
-18.11%
↑ 2.16%
Q4 FY23Q/Q Change
Revenue
276.7M
↑ 109.56%
Net Income
-1.2M
↓ 94.87%
Net Profit Margin
-0.44%
↑ 17.67%
Q1 FY24Q/Q Change
Revenue
185.6M
↓ 32.92%
Net Income
-9.2M
↑ 651.71%
Net Profit Margin
-4.97%
↓ 4.53%
FY18Y/Y Change
Total Assets
142.8M
-
Total Liabilities
329.5M
-
FY19Y/Y Change
Total Assets
1.6B
↑ 1021.76%
Total Liabilities
742.2M
↑ 125.24%
FY20Y/Y Change
Total Assets
2.1B
↑ 31.61%
Total Liabilities
709.6M
↓ 4.38%
FY21Y/Y Change
Total Assets
2.1B
↓ 1.89%
Total Liabilities
1.2B
↑ 65.77%
FY22Y/Y Change
Total Assets
1.7B
↓ 19.8%
Total Liabilities
1.1B
↓ 9.25%
FY23Y/Y Change
Total Assets
1.5B
↓ 9.63%
Total Liabilities
1.1B
↑ 2.47%
Q4 FY22Q/Q Change
Total Assets
1.7B
↓ 17.1%
Total Liabilities
1.1B
↓ 15.54%
Q1 FY23Q/Q Change
Total Assets
1.5B
↓ 6.98%
Total Liabilities
970.9M
↓ 9.06%
Q2 FY23Q/Q Change
Total Assets
1.5B
↓ 3.97%
Total Liabilities
972.2M
↑ 0.14%
Q3 FY23Q/Q Change
Total Assets
1.4B
↓ 3.03%
Total Liabilities
983.5M
↑ 1.16%
Q4 FY23Q/Q Change
Total Assets
1.5B
↑ 4.32%
Total Liabilities
1.1B
↑ 11.23%
Q1 FY24Q/Q Change
Total Assets
1.4B
↓ 6.96%
Total Liabilities
1.0B
↓ 7.71%
FY18Y/Y Change
Operating Cash Flow
5.4M
-
Investing Cash Flow
-6.2M
-
Financing Cash Flow
63.0K
-
FY19Y/Y Change
Operating Cash Flow
-3.0K
↓ 100.06%
Investing Cash Flow
-815.6M
↑ 13118.91%
Financing Cash Flow
827.4M
↑ 1313280.95%
FY20Y/Y Change
Operating Cash Flow
-114.2M
↑ 3807133.33%
Investing Cash Flow
-14.5M
↓ 98.22%
Financing Cash Flow
260.7M
↓ 68.5%
FY21Y/Y Change
Operating Cash Flow
-299.0M
↑ 161.79%
Investing Cash Flow
-19.8M
↑ 36.34%
Financing Cash Flow
259.1M
↓ 0.6%
FY22Y/Y Change
Operating Cash Flow
60.9M
↓ 120.37%
Investing Cash Flow
-13.5M
↓ 31.76%
Financing Cash Flow
-115.1M
↓ 144.41%
Q4 FY22Q/Q Change
Operating Cash Flow
-41.0M
↓ 142.92%
Investing Cash Flow
-1.4M
↓ 41.92%
Financing Cash Flow
-156.6M
↓ 440.39%
Q1 FY23Q/Q Change
Operating Cash Flow
20.5M
↓ 149.95%
Investing Cash Flow
-2.2M
↑ 57.2%
Financing Cash Flow
-2.4M
↓ 98.47%
Q2 FY23Q/Q Change
Operating Cash Flow
10.9M
↓ 46.97%
Investing Cash Flow
-2.4M
↑ 9.34%
Financing Cash Flow
-15.4M
↑ 543.68%

Technicals Summary

Sell

Neutral

Buy

Gohealth, Inc. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Gohealth, Inc.
Gohealth, Inc.
40.63%
7.74%
-26.43%
-90.52%
-95.42%
Willis Towers Watson Plc
Willis Towers Watson Plc
2.58%
6.33%
17.61%
23.39%
36.12%
Marsh & Mclennan Companies, Inc.
Marsh & Mclennan Companies, Inc.
1.13%
9.2%
16.04%
56.37%
116.12%
Arthur J Gallagher & Co.
Arthur J Gallagher & Co.
2.22%
13.29%
27.18%
97.99%
194.66%
Aon Plc
Aon Plc
1.04%
-3.82%
-9.9%
32.14%
53.75%
Brown & Brown Inc.
Brown & Brown Inc.
0.37%
24.59%
33.89%
77.01%
168.67%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Gohealth, Inc.
Gohealth, Inc.
NA
NA
NA
-5.7
-0.3
-0.03
NA
22.82
Willis Towers Watson Plc
Willis Towers Watson Plc
27.04
27.04
1.12
16.27
0.11
0.04
0.01
92.84
Marsh & Mclennan Companies, Inc.
Marsh & Mclennan Companies, Inc.
28.0
28.0
2.43
8.74
0.33
0.09
0.01
25.21
Arthur J Gallagher & Co.
Arthur J Gallagher & Co.
54.99
54.99
2.09
10.15
0.1
0.03
0.01
51.72
Aon Plc
Aon Plc
23.41
23.41
1.52
15.43
1.76
0.07
0.01
-0.67
Brown & Brown Inc.
Brown & Brown Inc.
28.87
28.87
4.41
3.64
0.17
0.06
0.01
20.27
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Gohealth, Inc.
Gohealth, Inc.
Buy
$317.7M
-95.42%
NA
-8.59%
Willis Towers Watson Plc
Willis Towers Watson Plc
Buy
$27.3B
36.12%
27.04
10.88%
Marsh & Mclennan Companies, Inc.
Marsh & Mclennan Companies, Inc.
Hold
$108.7B
116.12%
28.0
16.84%
Arthur J Gallagher & Co.
Arthur J Gallagher & Co.
Buy
$59.1B
194.66%
54.99
10.83%
Aon Plc
Aon Plc
Hold
$65.2B
53.75%
23.41
19.04%
Brown & Brown Inc.
Brown & Brown Inc.
Buy
$26.7B
168.67%
28.87
21.39%

Insights on Gohealth, Inc.

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 276.69M → 185.6M (in $), with an average decrease of 32.9% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -1.22M → -9.21M (in $), with an average decrease of 651.7% per quarter

  • Vs BRO

    In the last 1 year, Brown & Brown Inc. has given 33.9% return, outperforming this stock by 60.3%

  • Vs AJG

    In the last 3 years, Arthur J Gallagher & Co. has given 77.0% return, outperforming this stock by 167.5%

Institutional Holdings

  • Centerbridge Partners, L.P.

    42.02%
  • BlackRock Inc

    2.86%
  • Vanguard Group Inc

    2.08%
  • CI Private Wealth LLC

    1.64%
  • Geode Capital Management, LLC

    0.92%
  • Blue Owl Capital Holdings LP

    0.84%

Company Information

Organization
Gohealth, Inc.
Employees
2530
CEO
Mr. Brandon M. Cruz
Industry
Finance

FAQs